Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.22 EUR
659.43 M EUR
3.53 B EUR
About Coloplast A/S Class B
Sector
Industry
CEO
Lars Søren Rasmussen
Website
Headquarters
Humlebaek
Founded
1957
ISIN
US19624Y2000
FIGI
BBG0154CDVD9
Coloplast A/S engages in the developing, manufacture, and markets medical products. It operates through the following segments: Chronic Care, Voice and Respiratory Care, Interventional Urology, Advanced Wound Dressings, and Biologics. The Chronic Care segment covers the sale of ostomy care products and continence care products. The Voice and Respiratory Care segment refers to the sale of laryngectomy and tracheostomy products. The Interventional Urology segment includes the sale of urological products, including disposable products. The Advanced Wound Dressings segment focuses on the sale of wound and skin care products. The Biologics segment represents a new segment covering the sale of tissue-based products. The company was founded by Aage Louis-Hansen and Johanne Louise-Hansen in 1954 and is headquartered in Humlebaek, Denmark.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
XS248128852
Coloplast Finance BV 2.75% 19-MAY-2030Yield to maturity
—
Maturity date
May 19, 2030
XS248128780
Coloplast Finance BV 2.25% 19-MAY-2027Yield to maturity
—
Maturity date
May 19, 2027
See all CBH bonds